ArticleArXiv2025
Rational Multi-Modal Transformers for TCR-pMHC Prediction.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes is fundamental to adaptive immunity and central to the development of T cell-based immunotherapies. While transformer-based models have shown promise in predicting TCR-pMHC interactions, most lack a systematic and explainable approach to architecture design. We present an approach that uses a new post-hoc explainability method to inform the construction of a novel encoder-decoder transformer model. By identifying the most informative combinations of TCR and epitope sequence inputs, we optimize cross-attention strategies, incorporate auxiliary training objectives, and introduce a novel early-stopping criterion based on explanation quality. Our framework achieves state-of-the-art predictive performance while simultaneously improving explainability, robustness, and generalization. This work establishes a principled, explanation-driven strategy for modeling TCR-pMHC binding and offers mechanistic insights into sequence-level binding behavior through the lens of deep learning.
Indexed as
Identifiers
41040809PMC12486057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.